What sector does Zim Laboratories Limited belong to?

Zim Laboratories Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of ZIMLAB?

As of the latest available quote, ZIMLAB traded at ₹139.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ZIMLAB?

Zim Laboratories Limited has a price-to-earnings (P/E) ratio of about 169.51. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ZIMLAB?

The market capitalisation of Zim Laboratories Limited is approximately ₹747 Cr.

Is Zim Laboratories Limited profitable?

For its latest reported financial year, Zim Laboratories Limited recorded a net profit margin of about 1.60%.

Does ZIMLAB pay a dividend?

Zim Laboratories Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of ZIMLAB?

Zim Laboratories Limited has a return on equity (ROE) of about 1.59%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ZIMLAB?

Over the past 52 weeks, ZIMLAB has traded between a low of ₹59.31 and a high of ₹144.49.

Zim Laboratories Limited

ZIMLAB NSE Healthcare Pharmaceuticals

₹139.00

+1.88%

Delayed · cached 15 min

Fair value analysis

ZIMLAB

Zim Laboratories Limited

₹136.43

Close used for this calculation

₹44.19Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

24/100

Profitability4/25

Returns1/25

Balance Sheet17/25

Efficiency2/25

Growth0/25

Weak

Quality radar

Consensus fair value

₹44.19

Above FV

▼ -67.6% against the close used

Model range ₹5.46 – ₹68.12

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹5.46Fair value₹44.19Bull₹68.12

FairClose

52-week traded range

52W low ₹60.2652W high ₹136.43

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Zim Laboratories Limited closed at ₹136.43, 208.7% above the consensus fair value of ₹44.19 drawn from 7 valuation models.

Financial DNA score 24/100 — Weak. P/E of 202.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹37.65

-72.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹29.03

-78.7%

√(22.5 × EPS × BVPS)

EPS=1.09, BVPS=34.37 · outside Graham range (P/E 202, P/B 4) — asset-light, treat as a rough floor

P/E Fair Value

₹38.91

-71.5%

EPS × 35.7x (sector P/E)

EPS=1.09, Sector P/E=35.7x

EV/EBITDA

₹68.12

-50.1%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=500M

Book Value (P/B)

₹5.46

-96.0%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=34.37, ROE=1.6%, g=3%, r=10%

Reverse DCF

₹136.43

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 32.3% | Historical: 0%

Margin of Safety

₹26.40

-80.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=35.2, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer